CURIOSITYSTREAM INC(NASDAQ:CURI) stock Fundamental Analysis

Fundamental Rating

Overall CURI gets a fundamental rating of 3 out of 10. We evaluated CURI against 72 industry peers in the Entertainment industry. The financial health of CURI is average, but there are quite some concerns on its profitability. CURI is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CURI has reported negative net income.

In the past year CURI had a positive cash flow from operations.

In the past 5 years CURI always reported negative net income.

In the past 5 years CURI reported 4 times negative operating cash flow.

1.2 Ratios

CURI has a worse Return On Assets (-15.02%) than 68.06% of its industry peers.

CURI has a Return On Equity (-22.37%) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-15.02%
ROE	-22.37%
ROIC	N/A

ROA(3y)-32.15%

ROA(5y)-36.84%

ROE(3y)-44.33%

ROE(5y)-58.97%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CURI has a Gross Margin (50.40%) which is in line with its industry peers.

In the last couple of years the Gross Margin of CURI has remained more or less at the same level.

CURI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	50.4%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.26%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CURI does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, CURI has more shares outstanding

Compared to 5 years ago, CURI has more shares outstanding

There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -0.43, we must say that CURI is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of CURI (-0.43) is worse than 68.06% of its industry peers.

There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	-0.43

ROIC/WACCN/A

WACC9.04%

2.3 Liquidity

A Current Ratio of 1.66 indicates that CURI should not have too much problems paying its short term obligations.

CURI's Current ratio of 1.66 is fine compared to the rest of the industry. CURI outperforms 75.00% of its industry peers.

CURI has a Quick Ratio of 1.66. This is a normal value and indicates that CURI is financially healthy and should not expect problems in meeting its short term obligations.

CURI has a better Quick ratio (1.66) than 76.39% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.66
Quick Ratio	1.66

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CURI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.19%, which is quite impressive.

Looking at the last year, CURI shows a very negative growth in Revenue. The Revenue has decreased by -10.13% in the last year.

Measured over the past years, CURI shows a very negative growth in Revenue. The Revenue has been decreasing by -10.47% on average per year.

EPS 1Y (TTM)74.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%44.44%

Revenue 1Y (TTM)-10.13%

Revenue growth 3Y-10.47%

Revenue growth 5YN/A

Sales Q2Q%-4.34%

3.2 Future

Based on estimates for the next years, CURI will show a very strong growth in Earnings Per Share. The EPS will grow by 50.40% on average per year.

Based on estimates for the next years, CURI will show a quite strong growth in Revenue. The Revenue will grow by 13.02% on average per year.

EPS Next Y60.33%

EPS Next 2Y36.84%

EPS Next 3Y25.09%

EPS Next 5Y50.4%

Revenue Next Year14.48%

Revenue Next 2Y12.25%

Revenue Next 3Y11.72%

Revenue Next 5Y13.02%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CURI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year CURI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CURI indicates a somewhat cheap valuation: CURI is cheaper than 61.11% of the companies listed in the same industry.

72.22% of the companies in the same industry are more expensive than CURI, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	24.75
EV/EBITDA	22.92

4.3 Compensation for Growth

A more expensive valuation may be justified as CURI's earnings are expected to grow with 25.09% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y36.84%

EPS Next 3Y25.09%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.05%, CURI is a good candidate for dividend investing.

CURI's Dividend Yield is rather good when compared to the industry average which is at 7.42. CURI pays more dividend than 94.44% of the companies in the same industry.

Compared to an average S&P500 Dividend Yield of 2.51, CURI pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	5.05%

5.2 History

CURI does not have a reliable dividend history as it only pays dividend since a couple or years.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

The earnings of CURI are negative and hence is the payout ratio. CURI will probably not be able to sustain this dividend level.

DP-31.4%

EPS Next 2Y36.84%

EPS Next 3Y25.09%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CURIOSITYSTREAM INC

NASDAQ:CURI (4/24/2025, 8:01:45 PM)

Premarket: 3.51 +0.01 (+0.29%)

3.5

+0.03 (+0.86%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryEntertainment

Earnings (Last)03-11 2025-03-11/amc

Earnings (Next)05-13 2025-05-13/amc

Inst Owners9.39%

Inst Owner Change0.61%

Ins Owners6.48%

Ins Owner Change3.56%

Market Cap201.71M

Analysts82.22

Price Target2.81 (-19.71%)

Short Float %0.86%

Short Ratio0.94

Dividend

		Industry Rank	Sector Rank
Dividend Yield	5.05%

Yearly Dividend0.07

Dividend Growth(5Y)N/A

DP-31.4%

Div Incr Years0

Div Non Decr Years0

Ex-Date03-14 2025-03-14 (0.03)

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-80.14%

Min EPS beat(2)-83.8%

Max EPS beat(2)-76.49%

EPS beat(4)1

Avg EPS beat(4)-44.66%

Min EPS beat(4)-83.8%

Max EPS beat(4)28.7%

EPS beat(8)2

Avg EPS beat(8)-44.65%

EPS beat(12)5

Avg EPS beat(12)-34.56%

EPS beat(16)8

Avg EPS beat(16)-19.26%

Revenue beat(2)1

Avg Revenue beat(2)-2.91%

Min Revenue beat(2)-9.67%

Max Revenue beat(2)3.85%

Revenue beat(4)1

Avg Revenue beat(4)-2.51%

Min Revenue beat(4)-9.67%

Max Revenue beat(4)3.85%

Revenue beat(8)4

Avg Revenue beat(8)-0.8%

Revenue beat(12)6

Avg Revenue beat(12)-3.76%

Revenue beat(16)7

Avg Revenue beat(16)-3.82%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)-11.13%

EPS NQ rev (3m)-11.13%

EPS NY rev (1m)-33.33%

EPS NY rev (3m)-33.33%

Revenue NQ rev (1m)5.01%

Revenue NQ rev (3m)11.32%

Revenue NY rev (1m)4.85%

Revenue NY rev (3m)4.85%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.94
P/FCF	24.75
P/OCF	24.75
P/B	3.49
P/tB	7.66
EV/EBITDA	22.92

EPS(TTM)-0.24

EYN/A

EPS(NY)-0.1

Fwd EYN/A

FCF(TTM)0.14

FCFY4.04%

OCF(TTM)0.14

OCFY4.04%

SpS0.89

BVpS1

TBVpS0.46

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-15.02%
ROE	-22.37%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	50.4%
FCFM	15.94%

ROA(3y)-32.15%

ROA(5y)-36.84%

ROE(3y)-44.33%

ROE(5y)-58.97%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.26%

GM growth 5YN/A

F-Score7

Asset Turnover0.59

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	0%
Cap/Sales	0%
Interest Coverage	N/A
Cash Conversion	128.5%
Profit Quality	N/A
Current Ratio	1.66
Quick Ratio	1.66
Altman-Z	-0.43

F-Score7

WACC9.04%

ROIC/WACCN/A

Cap/Depr(3y)0.12%

Cap/Depr(5y)1.04%

Cap/Sales(3y)0.06%

Cap/Sales(5y)0.32%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)74.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%44.44%

EPS Next Y60.33%

EPS Next 2Y36.84%

EPS Next 3Y25.09%

EPS Next 5Y50.4%

Revenue 1Y (TTM)-10.13%

Revenue growth 3Y-10.47%

Revenue growth 5YN/A

Sales Q2Q%-4.34%

Revenue Next Year14.48%

Revenue Next 2Y12.25%

Revenue Next 3Y11.72%

Revenue Next 5Y13.02%

EBIT growth 1Y46.83%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year103.33%

EBIT Next 3Y37.77%

EBIT Next 5Y26.01%

FCF growth 1Y150.39%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y150.4%

OCF growth 3YN/A

OCF growth 5YN/A

CURIOSITYSTREAM INC (CURI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens